Rima Rakeshkumar Sahay

This study develops a multi-epitope vaccine candidate against KFDV using immunoinformatic tools, showing stable interaction with TLR2-TLR6 and codon optimization for prokaryotic expression.

This study evaluates the neutralizing antibody response of different groups against SARS-CoV-2 Delta and its derivatives using PRNT50.

The paper evaluates the neutralizing activity of sera from vaccinated and recovered individuals against SARS-CoV-2 Delta, Delta AY.1, and B.1.617.3 variants, finding reduced but still effective neutralization.

Sera from 26 BBV152/COVAXIN recipients neutralised the UK variant about as well as a heterologous strain in plaque reduction tests, arguing against escape from vaccine-induced antibodies.